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Strengths and limitations of this study
 ► This study is the first Asian nationwide study that 
reported the outcomes of paediatric tracheotomy 
depending on the indications.
 ► We used a nationwide insurance claims database 
that can track data for each patient, even if the pa-
tient visited or was hospitalised at multiple medical 
institutions.
 ► The severity and details of the indication of trache-
otomy could not be determined because of the lack 
of this type of information in the claims record; the 
accuracy of coding may be another limitation.
 ► In some patients, the durations of mechanical ven-
tilation and tracheotomy dependence may have 
continued after the follow- up period of this study, so 
we might have underestimated the durations of me-
chanical ventilation and tracheotomy dependence.
 ► The cause of death could not be identified from the 
database.
AbStrACt
Objective To examine the incidence of and indications 
for paediatric tracheotomy to clarify the disease burden 
relevant to tracheotomy in a population- based context.
Design A descriptive analysis of a retrospective cohort.
Setting This study utilised a nationwide claims 
database in Japan constructed by JMDC (Tokyo, Japan). 
The database includes claims data for approximately 
3.75 million insured persons (approximately 3.1% of 
the population of Japan) comprising mainly company 
employees and their family members.
Participants We identified children registered to have 
undergone tracheotomy from 2005 to 2017 among about 
1.2 million children aged 0–15 years.
Main outcome measures The characteristics of the 
study population, and indications for tracheotomy, duration 
of hospital stay, duration of mechanical ventilation, 
duration of tracheotomy dependence, complications 
related to tracheotomy and death were assessed. When 
there were multiple indications, classification for a child 
into multiple groups was allowed.
results The study included 215 children (120 males, 
56%). The median age at tracheotomy was 0.8 years. 
The most common age at tracheotomy was less than 12 
months (n=127, 59.1%). The most common indications 
for tracheotomy were chronic lung disease (n=79, 
36.7%), followed by neuromuscular disease (n=77, 
35.8%), cardiovascular disease (n=53, 24.3%), upper 
airway obstruction (n=43, 20%), premature birth and 
related conditions (n=34, 15.8%), trauma (n=16, 7.4%), 
prolonged ventilation due to other causes (n=12, 5.6%) 
and malignancy (n=9, 4.2%). The median duration of 
tracheotomy dependence was 17.2 months. During the 
follow- up period, decannulation was achieved in 84 
children (39.1%), and the median time from tracheotomy 
to decannulation was 12.0 months.
Conclusions Most paediatric tracheotomies were 
performed due to chronic underlying diseases, and the 
mean duration of tracheotomy dependence was nearly 
1-½ years. The long- term duration of tracheotomy 
dependence might have some impacts on patients’ 
physical and mental development and the quality of life.
IntrODuCtIOn
The common indications for paediatric trache-
otomy have changed from acute causes, such 
as respiratory tract infections and trauma, to 
chronic causes, such as neurological diseases 
and upper airway abnormalities. These 
changes have resulted from decreasing infec-
tion by introducing vaccines and preventing 
trauma patients from becoming serious due 
to advancements in treatment and tech-
nology over the past several decades.1 2 Due 
to the change in indications for paediatric 
tracheotomy, the duration of tracheotomy 
dependence has been increasing.1 2
The data regarding paediatric trache-
otomy mentioned above are derived from 
single- centre experiences or from nationwide 
surveys performed only in Western coun-
tries.3–11 Contemporarily, large- scale epidemi-
ological data from other regions may expand 
our knowledge. Some studies have reported 
that the outcomes of paediatric tracheotomy 
depend on the indications,5 6 8–11 but some of 
these studies are single- institutional studies, 
and their results could be influenced by 
specific practices of the institution such as the 
indication for tracheotomy and the timing 
of decannulation and discharge.8–11 Other 
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studies are multi- institutional studies, but the studies used 
data only during hospitalisation period.5 6 In chronic 
diseases, particularly tracheotomy- related outcomes such 
as decannulation, complication and mortality may occur 
not only during hospitalisation but also after discharge or 
at other medical facilities.
In this study, we aimed to examine the incidence of and, 
indications for paediatric tracheotomy and outcomes, 
such as the length of hospital stay, weaning from ventila-
tion, complications, decannulation and mortality, using 
a nationwide claims database that tracks data for each 
patient, even if the patient visited or was hospitalised 
at multiple medical institutions in Japan to clarify the 
disease burden relevant to tracheotomy.
MAterIAlS AnD MethODS
Data source
This descriptive study utilised a nationwide insurance 
claims database in Japan constructed by JMDC (Tokyo, 
Japan).12 JMDC is a commercial data vendor that collects 
data from >100 employer- based insurances. The database 
has accumulated reimbursement data from approximately 
3.75 million insured persons (approximately 3.1% of the 
population) mainly comprising company employees and 
their family members since 2005. The database contains 
the following information: patient characteristics (age 
and sex), medical and pharmacy claims data, clinical 
diagnoses coded using the International Classification 
of Diseases 10th revision (ICD-10) and medical proce-
dures coded using Japan- specific standardised procedure 
codes. The database can track data for each patient in 
chronological order, even if the patient visited or was 
hospitalised at multiple medical institutions. The need 
to obtain individual informed patient consent was waived 
because this study was a secondary analysis of an anony-
mous patient database.
Study cohort
From a database of about 1.2 million children, we extracted 
data for 215 children aged 0–15 years who underwent 
tracheotomy from 1 January 2005, to 31 December 2017. 
These patients were identified by the Japanese procedure 
code for tracheotomy (procedure code number: K386). 
Children who underwent two or more tracheotomies 
were excluded.
The following clinical data were collected: sex, age at 
tracheotomy, indications for tracheotomy, duration of 
hospital stay, duration of mechanical ventilation, dura-
tion of tracheotomy dependence, complications related 
to tracheotomy and death.
In this study, we identified indications for tracheotomy 
according to the ICD-10 codes for each child. We reviewed 
the ICD-10 codes both during hospitalisation when the 
tracheotomy was performed and at outpatient visits 
before hospitalisation. Indications for tracheotomy were 
categorised into the following groups: (1) neuromus-
cular disease (eg, hypoxic brain injury, encephalopathy, 
congenital anomalies of the central nervous system, 
muscular dystrophies, hydrocephalus), (2) upper airway 
obstruction (eg, congenital malformation, infection), (3) 
cardiovascular disease, (4) premature birth and related 
conditions, (5) trauma (eg, head injury, upper airway 
trauma, thoracic injury, burn injury), (6) chronic lung 
disease (eg, pneumonia, chronic obstructive pulmo-
nary disease, pulmonary hypoplasia), (7) malignancy 
(eg, brain neoplasm, haematological neoplasm, thyroid 
neoplasm) and (8) prolonged ventilation due to other 
causes (eg, gastrointestinal disease, liver disease, meta-
bolic disorder). When there were multiple indications, 
classification for a child into multiple groups was allowed.
From the claims record, we estimated the duration of 
mechanical ventilation and the duration of tracheotomy 
dependence of each patient by calculating the cumula-
tive days under ventilation use at both hospital and home. 
The duration of mechanical ventilation was determined 
by the date of additional use or the date a home manage-
ment fee for mechanical ventilation was added (proce-
dure code numbers: A306, A307, C107, C164, J026, 
J045), and the duration of tracheotomy dependence 
was determined by the date a home management fee 
for tracheotomy (procedure code number: C112) or the 
date a material cost for an artificial nose for tracheotomy 
patients was added (procedure code number: C169). 
The fees, additional use and material cost were added 
once a month, so the durations of mechanical ventila-
tion and tracheostomy dependence were calculated on 
a monthly basis. For the duration of mechanical venti-
lation, a continuous period including the month when 
tracheostomy was performed was used. The duration of 
tracheotomy dependence was calculated starting from 
the month when the tracheotomy was performed. The 
end of mechanical ventilation management was defined 
as the month that an additional use or fee was added for 
the last time and the month after which an additional use 
was not recorded for more than 3 months. The end of 
tracheotomy dependence was defined in the same way. 
The follow- up period of this study was from 1 January 
2005 to 31 December 2017.
Complications related to tracheotomy were identi-
fied by the diagnosis codes for dysfunction, obstruction, 
bleeding, infection of a stoma (ICD-10 code number: 
J950), intratracheal bleeding (ICD-10 code number: 
R048) and intratracheal granulation (ICD-10 code 
number: J398). We identified the complications that 
occurred within all available follow- up data including 
the index hospitalisation, outpatient visits and the subse-
quent hospitalisations (if they occurred). We calculated 
the risk of tracheotomy- related complications of all 
children included this study. It was difficult to ascertain 
whether pneumothorax and pneumonia were attributed 
to tracheotomy or other causes. Thus, in this study, we 
estimated the locally occurring complications of trache-
otomy listed above.
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Table 1 Clinical characteristics of paediatric patients 
undergoing tracheotomy
Total, n 215
Male sex, n (%) 120 (55.8)
Age at tracheotomy, median (IQR), years 0.8 (0.3–4.4)
  <12 months, n (%) 127 (59.1)
  1–5 years, n (%) 48 (22.3)
  6–10 years, n (%) 13 (6.0)
  11–15 years, n (%) 27 (12.6)
Indication for tracheotomy
  Chronic lung disease, n (%) 79 (36.7)
  Neuromuscular disease, n (%) 77 (35.8)
  Cardiovascular disease, n (%) 53 (24.2)
  Upper airway obstruction, n (%) 43 (20.0)
  Prematurity, n (%) 34 (15.8)
  Trauma, n (%) 16 (7.4)
  Prolonged ventilation, n (%) 12 (5.6)
  Malignancy, n (%) 9 (4.2)
  Hospital stay, median (Q1; Q3), months 5.8 (2.9; 12.2)
  Mechanical ventilation duration, median 
(Q1; Q3), months
9.0 (2.0; 23.0)
Duration for tracheotomy dependence, 
median (Q1; Q3), months
17.2 (4.1; 34.5)
Discharge with cannulation, n (%) 117 (54.4)
Never discharged during the study period, 
n (%)
47 (21.9)
Decannulation, n (%) 84 (39.1)
Period from tracheotomy to decannulation, 
median (Q1; Q3), months
12.0 (1.0; 28.3)
Complication related to tracheotomy, n 
(%)
45 (20.1)
Mortality, n (%) 31 (14.4)
Age at death, median, (IQR), years 0.7 (0.3–7.9)
Statistical analysis
The characteristics of the study population are 
summarised using proportions for categorical variables 
and medians and quantiles (Q1 (the first quantile), Q3 
(the third quantile)).
Mann- Whitney U test and Fisher’s exact test were used 
to compare continuous variables and categorical vari-
ables, respectively.
We performed univariable logistic regression analyses 
to evaluate the association between indications for trache-
otomy and its outcomes, such as discharge with cannu-
lation, occurrence of decannulation and mortality, and 
multivariable logistic regression analyses were used to 
evaluate the association between occurrences of compli-
cations related to tracheotomy, and age and duration of 
tracheotomy dependence. For duration of tracheotomy 
dependence, we used 2 years as a cut- off to divide the 
cohort for the analysis because Ha et al reported that 
the relative risk of a persistent tracheocutaneous fistula 
was significantly increased when the duration of trache-
ostomy dependence was greater than 2 years,2 and we 
assumed that other complications related to tracheotomy 
would also increase when the duration of tracheotomy 
dependence was longer than 2 years. The results were 
expressed as ORs with 95% CIs.
All statistical tests were two- sided; p<0.05 was considered 
statistically significant. All data analyses were performed 
using SAS for Windows (V.9.4; SAS Institute).
Patient and public involvement
Patients and the public were not involved in the study 
design or the conduct of the study.
reSultS
Demographics and clinical characteristics
From the JMDC database, we identified 215 children (120 
males, 56%) who underwent tracheotomy from 1 January 
2005 to 31 December 2017. Table 1 presents the demo-
graphic and clinical characteristics of the study cohort. 
The median age at tracheotomy was 0.8 years (IQR: 0.3–4.4 
years). Tracheotomies were performed most often when 
patients were younger than 12 months (n=127, 59.1%). 
The most common indications for tracheotomy were 
chronic lung disease (n=79, 36.7%), followed by neuro-
muscular disease (n=77, 35.8%), cardiovascular disease 
(n=53, 24.2%), upper airway obstruction (n=43, 20.0%), 
premature birth and related conditions (n=34, 15.8%), 
trauma (n=16, 7.4%), prolonged ventilation (n=12, 5.6%) 
and malignancy (n=9, 4.2%). Ninety- six children (44.7%) 
had two or more indications. Chronic lung disease and 
neuromuscular disease (n=31) were the most commonly 
paired indications, followed by chronic lung disease and 
premature birth. In the upper airway obstruction group, 
congenital malformation was the most common cause 
(n=38, 88.3%), followed by benign tumours (n=3) and 
infection (n=2). The median duration of tracheotomy 
dependence of all children included this study was 17.2 
months (Q1: 4.1 months; Q3: 34.5 months). One hundred 
seventeen children (54.4%) were discharged with cannu-
lation. During the follow- up period, decannulation was 
achieved in 84 children (39.1%), and the median time 
from tracheotomy to decannulation was 12.0 months 
(Q1: 1.0 month; Q3: 28.3 months) in these children. The 
number of deaths from all causes was 31 (14.4%), and the 
mean age at death was 3.7 years.
Subgroup analysis according to indications
The age at tracheotomy was different depending on the 
indications. Tracheotomy was performed later in children 
with malignancy (median age, 11.0 years, p<0.0001) than 
in children without malignancy and later in children with 
trauma (median age, 8.2 years, p<0.0001) than in chil-
dren without trauma.
The duration of hospitalisation tended to be short 
in children with prolonged ventilation due to other 
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Table 4 Multivariable logistic regression analysis of risk 
factors for occurrence of complications
OR, 95% CI P value
Age
  <12 months 1 (reference)
  1–5 years 1.76 (0.80 to 3.90) 0.11
  6–10 years 0.89 (0.18 to 4.47) 0.84
  11–15 years 0.65 (0.17 to 2.40) 0.40
Duration for tracheotomy dependence
  <2 years 1 (reference)
  ≥2 years 3.74 (1.87 to 7.1) 0.0002
Table 2 Univariate analysis for duration for tracheotomy dependence with or without each disease
Duration for tracheotomy dependence, median (IQR), months
P valueWith the disease* Without the disease*
Chronic lung disease 32.5 (4.1–32.5) 15.7 (3.6–36.5) 0.60
Neuromuscular disease 19.3 (12.1–41.6) 11.2 (2.0–29.4) 0.0028
Cardiovascular disease 11.2 (4.1–31.4) 17.3 (4.0–35.5) 0.42
Upper airway obstruction 18.3 (5.1–36.5) 16.7 (4.0–33.0) 0.59
Prematurity 20.3 (10.1–28.3) 16.2 (4.0–35.5) 0.58
Trauma 2.5 (0.5–26.4) 17.3 (5.1–34.5) 0.031
Prolonged ventilation 22.3 (1.0–40.6) 16.2 (4.1–33.5) 0.83
Malignancy 0 (0–2.0) 17.3 (4.1–35.5) 0.0003
*With or without the disease showed each left column.
Table 3 ORs for univariate regression analysis of discharge 
with cannulation according to the presence of each disease
Discharge with 
cannulation, OR 
(95% CI)* P value
Chronic lung disease 1.09 (0.62 to 1.89) 0.77
Neuromuscular disease 2.1 (1.2 to 3.8) 0.047
Cardiovascular disease 1.19 (0.63 to 2.24) 0.59
Upper airway obstruction 1.54 (0.77 to 3.06) 0.22
Prematurity 1.24 (0.59 to 2.6) 0.57
Trauma 0.25 (0.08 to 0.81) 0.021
Prolonged ventilation 0.26 (0.07 to 0.99) 0.048
Malignancy 0.097 (0.01 to 0.79) 0.029
causes (median, 3.9 months) and malignancy (median, 
4.0 months), but there was no statistical significance. 
The duration of mechanical ventilation was longer in 
children with neuromuscular disease (median, 16.0 
months, p=0.0011) than in children without neuromus-
cular disease. Table 2 shows duration for tracheotomy 
dependence with or without each disease. The duration 
of tracheotomy dependence was longer in children with 
neuromuscular disease (median, 19.3 months, p=0.0028) 
than in children without neuromuscular disease. Among 
children with chronic lung disease, neuromuscular 
disease, cardiovascular disease, upper airway obstruction 
or premature birth and related conditions, more than 
half were discharged with cannulation, whereas among 
children with trauma, prolonged ventilation or malig-
nancy, one- quarter or fewer were discharged with cannu-
lation. Table 3 shows ORs for discharge with cannulation 
according to the presence of each disease. The rate of 
discharge with cannulation was significantly higher in 
children with neuromuscular disease (OR, 2.1; 95% CI, 
1.2 to 3.8, p=0.047) than in children without neuro-
muscular disease. Decannulation was achieved in more 
than half of children with trauma (62.5%), prolonged 
ventilation (66.7%) or malignancy (55.6%). The rate of 
achievement of decannulation was the lowest in children 
with cardiovascular disease (30.1%), but there was no 
significant difference compared with children without 
cardiovascular disease. Mortality was significantly higher 
in children with cardiovascular disease (OR, 2.7; 95% CI, 
1.2 to 6.0, p<0.0001) than in children without cardiovas-
cular disease.
Complications
In total, 64 adverse events related to tracheotomy 
occurred in 45 children (20.1%). The most common 
adverse event was intratracheal granulation (n=38, 
59.3%). The first adverse event was most likely to occur 
3 months to 1 year after tracheotomy (n=19, 42.2%), 
and only 8.9% of first adverse events occurred 2 years 
after the tracheotomy. Adverse events were more likely 
to occur in patients with tracheotomy dependence for 
2 years or more, than in those with tracheotomy depen-
dence for less than 2 years (n=27, 60.0%, p<0.01). Multi-
variable logistic regression analysis revealed that age 
was not significantly associated with the occurrence of 
adverse events, and a 2- year or longer duration of trache-
otomy dependence was significantly associated with the 
occurrence of adverse events (OR, 3.74; 95% CI, 1.587 
to 7.51) (table 4).
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DISCuSSIOn
In this descriptive study, we investigated the incidence, 
indications and outcomes of paediatric tracheotomy in 
Japan, such as the length of hospital stay, weaning from 
ventilation, complications, decannulation and mortality.
Age and indications
As in recent studies, we found that tracheotomies were 
performed most often when patients were less than 12 
months old (n=127, 59.1%).5–8 13 In the premature birth 
and related conditions and neuromuscular disease 
groups in our study, most tracheotomies were performed 
within the first year of life, possibly due to the high rate 
of comorbidities among preterm infants who survived 
beyond the neonatal period.14
We accounted for children with multiple indications 
for tracheotomy because children with a chronic medical 
condition might have two or more comorbidities. In our 
study, 44.7% of children who underwent tracheotomy 
had two or more indications, and this rate was 60% in a 
previous study.5
Table 5 summarises the indications for trache-
otomy from previous studies after 1997. Table 5 shows 
some representative studies reporting indications and 
outcomes of paediatric tracheotomy over the most recent 
two decades. The frequency of each indication varied 
depending on the study, possibly because the method of 
classifying indications varied, and some studies allowed 
children to have multiple indications while others did 
not. In our study, chronic lung disease was the most 
common indication for tracheotomy, similar to previous 
studies that also allowed children to have multiple indi-
cations for tracheotomy.5 7 13 The most commonly paired 
indications were chronic lung disease and neuromuscular 
disease, consistent with one of the previous studies.5 Due 
to respiratory muscle weakness, recurrent aspiration, 
poor cough and airway clearance, and chest wall defor-
mity by kyphoscoliosis, neuromuscular disease increases 
the risk of respiratory difficulties.15 When evaluating the 
frequency for each indication, chronic lung disease was 
the most common indication for tracheotomy, followed 
by neuromuscular disease, which might be a consequence 
of the increasing survival of children with conditions such 
as neonatal intracranial haemorrhage, encephalitis and 
hypoxic encephalopathy. The second most commonly 
paired indications were chronic lung disease and prema-
ture birth. This could be because premature infants have 
complex and severe physical disabilities, and children 
with such disabilities often have respiratory problems.
Upper airway obstruction was the fourth most common 
indication for tracheostomy in our study. Among the 
causes of upper airway obstruction, congenital malfor-
mations were the main indications for tracheotomy, and 
only a few tracheotomies were performed for infections 
in our study and in previous studies,8 9 11 probably due to 
the widespread use of vaccination, such as the H. influ-
enzae type B and pneumococcal conjugate vaccines, and 
the decrease in the occurrence of severe infection.4
Cannulation and decannulation
The duration of tracheotomy dependence and the rate 
of decannulation vary depending on the underlying 
diseases.10 In patients who had trauma, the duration of 
tracheotomy dependence was relatively shorter, and the 
rate of decannulation was higher than in congenital or 
chronic disease patients, which was consistent with the 
findings of previous studies.8–10 The rate of decannula-
tion has decreased over time.1 The rate of decannulation 
varies between studies from 8.8% to 42.0%, even when 
only comparing studies conducted after 1997.1 5 8 10 The 
overall rate of decannulation was 39.1% in our study 
which was within the range of that from previous studies. 
The variation in the decannulation rate between studies 
may be related to patient characteristics, especially the 
underlying disease and follow- up periods. In our study, 
we used a nationwide insurance claims database that 
tracked data for each patient, even if the patient visited 
or was hospitalised at multiple medical institutions. The 
use of this database helped us to prevent underestimating 
the rate of decannulation missed during follow- up when 
patients were transferred to other hospitals.
Complications related to tracheotomy and mortality
As in previous studies, the most common complication 
related to tracheotomy in this study was intratracheal 
granulation.8 9 Adverse events were more likely to occur 
in patients with tracheotomy dependence for 2 years or 
more, whereas in most patients, the first adverse event 
occurred within 2 years after tracheotomy. Children who 
require long- term tracheotomy may tend to have compli-
cations due to a poor general condition such as malnu-
trition, immunocompromise, bleeding tendency and 
metabolic disorders.
In our study, cardiovascular disease was associated 
with higher mortality, similar to a previous study.6 In 
this previous study, Berry et al concluded that congenital 
heart disease, prematurity, absence of an upper airway 
anomaly and age <1 year were characteristics associated 
with higher mortality.
limitations
There were several limitations of this study that should 
be considered. First, the database used in this study was 
collected for billing purposes, and we could not obtain 
detailed clinical information for certain conditions. 
We estimated the indications for tracheotomy from the 
disease codes, but we could not determine the severity and 
detailed conditions of the diseases. Furthermore, it was 
difficult to make precise comparisons across the literature 
due to varying classifications for indications. Second, in 
some patients, we may have underestimated the durations 
of mechanical ventilation and tracheotomy dependence 
as they may have continued after the follow- up period of 
this study. Third, adverse events without diagnosis codes, 
such as accidental decannulation, could not be identi-
fied. The complication rate was 20.1% in our study, which 
was lower than those of previous studies, which range 
.
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from 22%–43%.1 8 9 Fourth, the cause of death could not 
be identified from the database. According to previous 
studies, the tracheostomy- related mortality rates ranged 
from 0% to 4%, and the most common cause was acci-
dental decannulation.1 9 The overall mortality rate was 
14.4% in our study, similar to the 15%–20% mortality 
rates observed in previous studies.1 9 Fifth, the JMDC 
database may not reflect the population of all paediatric 
patients with tracheostomy in Japan because the coverage 
rate of the database was 3% of the Japanese population. 
However, we assume that the characteristics of our patient 
population were similar to those of the whole paediatric 
patient population with tracheotomy in Japan. The first 
reason for this assumption is the low medical cost for 
caregivers. In most regions in Japan, medical expenses 
for children are largely covered by public support and are 
virtually free for parents. This situation allows physicians 
to deliver universal care to children if medically indi-
cated, regardless of insurance type or, caregivers’ socio-
economic status or income. Second, access to a medical 
institution is relatively easy, and the waiting list is not very 
long, even in specialised centres. For these reasons, chil-
dren in Japan can adequately receive medical care in a 
timely manner, irrespective of their insurance type or 
caregivers’ socioeconomic status.
In summary, this descriptive study using a nationwide 
insurance claims database demonstrated that paediatric 
tracheotomies in Japan were performed most often 
when patients were younger than 12 months, and the 
most common indication for tracheotomy was chronic 
lung disease. This study adds to the existing literature by 
providing an analysis of children who underwent trache-
otomy tracked across multiple hospitals and is the first 
multi- institutional analysis in an Asian country. In patients 
with chronic lung disease, neuromuscular disease, upper 
airway obstruction or cardiovascular disease, more than 
half were discharged with cannulation, and the duration 
of tracheotomy dependence was longer and the decan-
nulation rate was lower than in patients who had trauma. 
The long- term duration of tracheotomy dependence 
might have some impact on patients’ physical and mental 
development and the quality of life of the patients and 
their families. Further research should be necessary to 
investigate further changes in the indications for paedi-
atric tracheotomy, the prognosis after tracheotomy and 
the quality of life of patients and their families.
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